FDA Approved Products
190 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
POTASSIUM PHOSPHATES IN 0.9% SODIUM CHLORIDE
potassium phosphates in sodium chloride
Growth
INTRAVENOUS · SOLUTION
2024
NDA30/100
TERIPARATIDE
teriparatide
Growth
SUBCUTANEOUS · SOLUTION
2024
PeptideNDA30/100
VASOPRESSIN IN SODIUM CHLORIDE 0.9%
vasopressin
Growth
INTRAVENOUS · SOLUTION
2024
NDA30/100
VOQUEZNA
vonoprazan fumarate
Growth
Phathom Pharmaceuticals
ORAL · TABLET
2024
NDA30/100
ZITUVIMET
sitagliptin and metformin hydrochloride
Growth
ORAL · TABLET
2023
NDA30/100
ZITUVIMET XR
sitagliptin and metformin hydrochloride
Growth
ORAL · TABLET, EXTENDED RELEASE
2024
NDA30/100
ZOLPIDEM TARTRATE
zolpidem tartrate
Growth
Almatica Pharma
ORAL · CAPSULE
2023
NDA30/100
IOMERVU
iomeprol injection
Growth
Bracco
INTRA-ARTERIAL · SOLUTION
2024
NDA18/100
IOMERVU
iomeprol
Growth
Bracco
INTRAVENOUS · SOLUTION
2024
NDA18/100
ZEVTERA
ceftobiprole medocaril sodium
Growth
INTRAVENOUS · POWDER
2024
NDA18/100
EXXUA
gepirone
Growth
Fabre-Kramer Pharmaceuticals
ORAL · TABLET, EXTENDED RELEASE
major depressive disorder (MDD) in adults ( )
2023
NDA8/100
GRAFAPEX
treosulfan
Growth
Medexus Pharmaceuticals
INTRAVENOUS · POWDER
combination with fludarabineolder with acute myeloid leukemia (AML)+1
2025
NDA8/100
IDOSE TR
travoprost intracameral
Growth
Glaukos
INTRACAMERAL · IMPLANT
intraocular pressure (IOP) in patients with open-angle glaucoma (OAG)ocular hypertension (OHT)+2
2023
NDA8/100
INPEFA
sotagliflozin
Growth
Lexicon Pharmaceuticals
ORAL · TABLET
2023
SMNDA8/100
LUMIFY PRESERVATIVE FREE
brimonidine tartrate
Growth
Bausch + Lomb
OPHTHALMIC · SOLUTION/DROPS
2024
NDA8/100
MIPLYFFA
arimoclomol citrate
Growth
ORAL · CAPSULE
2024
NDA8/100
OPSYNVI
macitentan and tadalafil
Growth
Johnson & Johnson
ORAL · TABLET
2024
NDA8/100
RALDESY
trazodone hydrochloride oral
Growth
ORAL · SOLUTION
2024
NDA8/100
SYMBICORT AEROSPHERE
budesonide; formoterol fumarate
Growth
AstraZeneca
INHALATION · AEROSOL, METERED
2023
NDA8/100
VOQUEZNA
vonoprazan fumarate
Growth
Phathom Pharmaceuticals
ORAL · TABLET
2023
NDA8/100
XALKORI
crizotinib
Growth
Pfizer
ORAL · CAPSULE, PELLETS
2023
SMNDA8/100
ABILIFY ASIMTUFII
aripiprazole
Growth
Otsuka
INTRAMUSCULAR · SUSPENSION, EXTENDED RELEASE
schizophreniafor the treatment of schizophrenia
2023
SMNDA0/100
ADRENALIN
epinephrine in sodium chloride
Growth
Pfizer
INTRAVENOUS · SOLUTION
2023
NDA0/100
AGAMREE
vamorolone
Growth
Catalyst Pharmaceuticals
ORAL · SUSPENSION
Duchenne muscular dystrophy (DMD) in patients 2 years of ageolder
2023
NDA0/100